Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Andrew D Goodman, Nidhiben Anadani & Lee Gerwitz. (2019) Siponimod in the treatment of multiple sclerosis. Expert Opinion on Investigational Drugs 28:12, pages 1051-1057.
Read now
Read now
Tatiana Bakaeva & Sashank Prasad. (2019) For Massachusetts Eye and Ear Special Issue: Updates on Therapies for Multiple Sclerosis for the Ophthalmologist. Seminars in Ophthalmology 34:4, pages 270-278.
Read now
Read now
Judith A Hampson, Alice M Turner & Robert A Stockley. (2014) Polyclonal free light chains: promising new biomarkers in inflammatory disease. Current Biomarker Findings 4, pages 139-149.
Read now
Read now
Jack C Sipe. (2010) Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis. Expert Review of Neurotherapeutics 10:3, pages 365-375.
Read now
Read now
C. Govarts, K. Somers, R. Hupperts, P. Stinissen & V. Somers. (2009) Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient. Autoimmunity 42:8, pages 699-704.
Read now
Read now
Olaf Stüve, Petra D Cravens & Todd N Eagar. (2008) DNA-based vaccines: the future of multiple sclerosis therapy?. Expert Review of Neurotherapeutics 8:3, pages 351-360.
Read now
Read now
Alireza Minagar. (2006) Multiple sclerosis: current knowledge and future directions. Neurological Research 28:3, pages 227-229.
Read now
Read now
Articles from other publishers (58)
Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae & Yoe-Sik Bae. (2023) Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Frontiers in Immunology 14.
Crossref
Crossref
Erik I. Hallin, Trond Trætteberg Serkland, Kjell-Morten Myhr, Øivind Torkildsen & Silje Skrede. (2022) Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry. Journal of Mass Spectrometry and Advances in the Clinical Lab 25, pages 53-60.
Crossref
Crossref
Zamin Ahmad, Tariq Ahmad Shah, K. Pratap Reddy, Sudip Ghosh, Virendra Panpatil, Sandeep Kumar Kottoru, Sheikh Rayees & D. Raghunatha Rao. 2022. Fundamentals and Advances in Medical Biotechnology. Fundamentals and Advances in Medical Biotechnology
179
207
.
Tilman Robinson, Ahmed Abdelhak, Tanima Bose, Edgar Meinl, Markus Otto, Uwe K. Zettl, Rick Dersch, Hayrettin Tumani, Sebastian Rauer & André Huss. (2020) Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis. Cells 9:12, pages 2543.
Crossref
Crossref
Johan Linden, Gabriel Granåsen, Jonatan Salzer, Anders Svenningsson & Peter Sundström. (2019) Inflammatory activity and vitamin D levels in an MS population treated with rituximab. Multiple Sclerosis Journal - Experimental, Translational and Clinical 5:1, pages 205521731982659.
Crossref
Crossref
Yeseul Kim, Gayoung Kim, Hyun-June Shin, Jae-Won Hyun, Su-Hyun Kim, Eunjig Lee & Ho Jin Kim. (2018) Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis. Journal of Neuroinflammation 15:1.
Crossref
Crossref
Dimitrios Karussis & Panayiota Petrou. (2018) Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale. Immunologic Research 66:6, pages 642-648.
Crossref
Crossref
Chriselle D. Braganza, Kristiana T. Santoso, Emma M. Dangerfield, Anne C. La Flamme, Mattie S. M. Timmer & Bridget L. Stocker. (2018)
Evaluation of anti α-
d
-Glc
p
-(1→4)-α-
d
-Glc
p
(GAGA4) IgM antibodies as a biomarker for multiple sclerosis
. RSC Advances 8:49, pages 28086-28093.
Crossref
Crossref
Yiting Liu, Katherine S. Given, Danielle E. Harlow, Adeline M. Matschulat, Wendy B. Macklin, Jeffrey L. Bennett & Gregory P. Owens. (2017) Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination. Acta Neuropathologica Communications 5:1.
Crossref
Crossref
Jeffrey R. Atkinson & Cornelia C. Bergmann. (2017) Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis. Journal of Virology 91:23.
Crossref
Crossref
Serkan Ozakbas, Bilge Piri Cinar, Pinar Özcelik, Hatice Baser & Gorkem Kosehasanoğullari. (2017) Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results. Clinical Neurology and Neurosurgery 160, pages 27-29.
Crossref
Crossref
G. S. Makshakov, S. V. Lapin & E. P. Evdoshenko. (2017) Current Concepts of the Intrathecal Humoral Immune Response and the Diagnostic Significance of the Detection of Oligoclonal Immunoglobulins in Multiple Sclerosis. Neuroscience and Behavioral Physiology 47:5, pages 534-539.
Crossref
Crossref
Kimihiko Kaneko, Ichiro Nakashima & Kazuo Fujihara. (2017) Congress report of the 9th Pan‐Asian Committee for Treatment and Research in Multiple Sclerosis. Clinical and Experimental Neuroimmunology 8:1, pages 87-90.
Crossref
Crossref
Dimitrios Karussis. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health
145
179
.
Kaushiki Biswas, Dhriti Chatterjee, Sankar Addya, Reas S. Khan, Lawrence C. Kenyon, Alexander Choe, Randall J. Cohrs, Kenneth S. Shindler & Jayasri Das Sarma. (2016) Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination. Clinical Immunology 170, pages 9-19.
Crossref
Crossref
G. S. Makshakov, S. V. Lapin & E. P. Evdoshenko. (2016) Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:2. Vyp. 2, pages 14.
Crossref
Crossref
J. Nicholas Brenton & Brenda L. Banwell. (2015) Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis. Neurotherapeutics 13:1, pages 84-95.
Crossref
Crossref
Helle H. Nielsen, Hans C. Beck, Lars P. Kristensen, Mark Burton, Tunde Csepany, Magdolna Simo, Peter Dioszeghy, Tobias Sejbaek, Manuela Grebing, Niels H. H. Heegaard & Zsolt Illes. (2015) The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study. PLOS ONE 10:10, pages e0139659.
Crossref
Crossref
Pietro B. Carrieri, Fortunata Carbone, Francesco Perna, Dario Bruzzese, Claudia La Rocca, Mario Galgani, Silvana Montella, Maria Petracca, Ciro Florio, Giorgia T. Maniscalco, Daniele L.A. Spitaleri, Gerardo Iuliano, Gioacchino Tedeschi, Marida Della Corte, Simona Bonavita & Giuseppe Matarese. (2015) Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. Metabolism 64:9, pages 1112-1121.
Crossref
Crossref
Giulia Mallucci, Luca Peruzzotti-Jametti, Joshua D. Bernstock & Stefano Pluchino. (2015) The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis. Progress in Neurobiology 127-128, pages 1-22.
Crossref
Crossref
Daniele Pepe & Mario Grassi. (2014) Investigating perturbed pathway modules from gene expression data via structural equation models. BMC Bioinformatics 15:1.
Crossref
Crossref
William H. Rounds, Ann J. Ligocki, Mikhail K. Levin, Benjamin M. Greenberg, Douglas W. Bigwood, Eric M. Eastman, Lindsay G. Cowell & Nancy L. Monson. (2014) The Antibody Genetics of Multiple Sclerosis: Comparing Next-Generation Sequencing to Sanger Sequencing. Frontiers in Neurology 5.
Crossref
Crossref
Alireza Minagar. (2014) Multiple Sclerosis: An Overview of Clinical Features, Pathophysiology, Neuroimaging, and Treatment Options. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 6:4, pages 1-117.
Crossref
Crossref
Timothy W. Phares, Krista D. DiSano, Stephen A. Stohlman & Cornelia C. Bergmann. (2014)
Progression From IgD
+
IgM
+
to Isotype-Switched B Cells Is Site Specific during Coronavirus-Induced Encephalomyelitis
. Journal of Virology 88:16, pages 8853-8867.
Crossref
Crossref
Dimitrios Karussis & Panayiota Petrou. (2014) The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmunity Reviews 13:3, pages 215-224.
Crossref
Crossref
Per S. SorensenSteen LisbyRichard GroveFrederick DerosierSteve ShackelfordEva HavrdovaJelena DrulovicMassimo Filippi. (2014) Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis. Neurology 82:7, pages 573-581.
Crossref
Crossref
Dimitrios Karussis. (2014) The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review. Journal of Autoimmunity 48-49, pages 134-142.
Crossref
Crossref
Dimitrios Karussis. (2013) Immunotherapy of Multiple Sclerosis. BioDrugs 27:2, pages 113-148.
Crossref
Crossref
Timothy Phares, Stephen Stohlman & Cornelia Bergmann. (2013) Intrathecal Humoral Immunity to Encephalitic RNA Viruses. Viruses 5:2, pages 732-752.
Crossref
Crossref
A. Sicard, T.W. Phares, H. Yu, R. Fan, W.M. BaldwinIIIIII, R.L. Fairchild & A. Valujskikh. (2012) The Spleen Is the Major Source of Antidonor Antibody-Secreting Cells in Murine Heart Allograft Recipients. American Journal of Transplantation 12:7, pages 1708-1719.
Crossref
Crossref
Claudia Sievers, Maria Meira, Francine Hoffmann, Paulo Fontoura, Ludwig Kappos & Raija L.P. Lindberg. (2012) Altered microRNA expression in B lymphocytes in multiple sclerosis. Clinical Immunology 144:1, pages 70-79.
Crossref
Crossref
Manohar B. Mutnal, Shuxian Hu & James R. Lokensgard. (2012) Persistent Humoral Immune Responses in the CNS Limit Recovery of Reactivated Murine Cytomegalovirus. PLoS ONE 7:3, pages e33143.
Crossref
Crossref
S. Haghighi, A. Lekman, S. Nilsson, M. Blomqvist & O. Andersen. (2012) Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis. Acta Neurologica Scandinavica 125:1, pages 64-70.
Crossref
Crossref
Ruth Dobson, Ute C. Meier & Gavin Giovannoni. (2011) More to come: Humoral immune responses in MS. Journal of Neuroimmunology 240-241, pages 13-21.
Crossref
Crossref
Gavin Giovannoni & Stuart D. Cook. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics
358
369
.
. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics
300
582
.
Kathryn M. Brennan, Francesc Galban-Horcajo, Simon Rinaldi, Colin P. O'Leary, Carl S. Goodyear, Gabriela Kalna, Ariel Arthur, Christina Elliot, Sue Barnett, Christopher Linington, Jeffrey L. Bennett, Gregory P. Owens & Hugh J. Willison. (2011) Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis. Journal of Neuroimmunology 238:1-2, pages 87-95.
Crossref
Crossref
Cristina P. Marques, Parul Kapil, David R. Hinton, Claudia Hindinger, Stephen L. Nutt, Richard M. Ransohoff, Timothy W. Phares, Stephen A. Stohlman & Cornelia C. Bergmann. (2011) CXCR3-Dependent Plasma Blast Migration to the Central Nervous System during Viral Encephalomyelitis. Journal of Virology 85:13, pages 6136-6147.
Crossref
Crossref
Cecilia Ahlgren, Anders Odén, Sara Haghighi, Oluf Andersen, Tomas Bergström & Jan Lycke. (2011) The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome. Journal of Neuroimmunology 235:1-2, pages 98-103.
Crossref
Crossref
Mehrdad Alirezaei, Christopher C. Kemball & J. Lindsay Whitton. (2011) Autophagy, inflammation and neurodegenerative disease. European Journal of Neuroscience 33:2, pages 197-204.
Crossref
Crossref
Amer M. Awad & Olaf Stüve. (2010) IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS. CONTINUUM: Lifelong Learning in Neurology 16, pages 166-180.
Crossref
Crossref
Corey T. Watson, Sreeram V. Ramagopalan, Katie M. Morrison, George C. Ebers & Felix Breden. (2010) IGHV4-39 deletion polymorphism does not associate with risk or outcome of multiple sclerosis. Journal of Neuroimmunology 225:1-2, pages 164-166.
Crossref
Crossref
Hans-Peter HartungBernd C. Kieseier. (2010) Atacicept: targeting B cells in multiple sclerosis. Therapeutic Advances in Neurological Disorders 3:4, pages 205-216.
Crossref
Crossref
Anne Lise K. Hestvik. (2010) The Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis. Toxins 2:4, pages 856-877.
Crossref
Crossref
E. Trevisan, E. Fabbretti, N. Medic, B. Troian, S. Prato, F. Vita, G. Zabucchi & M. Zweyer. (2010) Novel approaches for scanning near-field optical microscopy imaging of oligodendrocytes in culture. NeuroImage 49:1, pages 517-524.
Crossref
Crossref
MATTHEW P. FROSCH, DOUGLAS C. ANTHONY & UMBERTO DE GIROLAMI. 2010. Robbins and Cotran Pathologic Basis of Disease. Robbins and Cotran Pathologic Basis of Disease
1279
1344
.
H.-P. Hartung. (2009) Atacicept bei Multipler SkleroseAtacicept: a new B lymphocyte-targeted therapy for multiple sclerosis. Der Nervenarzt 80:12, pages 1462-1472.
Crossref
Crossref
Kathleen Hawker, Paul O'Connor, Mark S. Freedman, Peter A. Calabresi, Jack Antel, Jack Simon, Stephen Hauser, Emmanuelle Waubant, Timothy Vollmer, Hillel Panitch, Jiameng Zhang, Peter Chin & Craig H. Smith. (2009) Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial. Annals of Neurology 66:4, pages 460-471.
Crossref
Crossref
Cecilia Ahlgren, Kjell Torén, Anders Odén & Oluf Andersen. (2009) A population-based case–control study on viral infections and vaccinations and subsequent multiple sclerosis risk. European Journal of Epidemiology 24:9, pages 541-552.
Crossref
Crossref
H Zéphir, D Lefranc, S Dubucquoi, J de Seze, L Boron, L Prin & P Vermersch. (2009) Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis. Multiple Sclerosis Journal 15:5, pages 593-600.
Crossref
Crossref
C. Ahlgren, A. Odén, K. Torén & O. Andersen. (2009) Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurologica Scandinavica 119:5, pages 313-320.
Crossref
Crossref
Jeffrey L. Bennett & Olaf Stüve. (2009) Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis. Clinical Neuropharmacology 32:3, pages 121-132.
Crossref
Crossref
Diego Franciotta, Marco Salvetti, Francesco Lolli, Barbara Serafini & Francesca Aloisi. (2008) B cells and multiple sclerosis. The Lancet Neurology 7:9, pages 852-858.
Crossref
Crossref
Xiaochang Xue, Guodong Feng, Meng Li, Xin Qin, Shouzhen Wu, Cun Zhang, Yanjie You, Weihua Wang, Changli Jiang, Yan Liu, Wenhua Zhu, Yonggang Ran, Zhen Zhang, Zhen Yan, Wei Han & Yingqi Zhang. (2008) Amelioration of experimental autoimmune encephalomyelitis by BLyS autovaccine. Vaccine 26:23, pages 2873-2881.
Crossref
Crossref
Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold, Timothy Vollmer, Jack Antel, Robert J. Fox, Amit Bar-Or, Michael Panzara, Neena Sarkar, Sunil Agarwal, Annette Langer-Gould & Craig H. Smith. (2008) B-Cell Depletion with Rituximab in Relapsing?Remitting Multiple Sclerosis. New England Journal of Medicine 358:7, pages 676-688.
Crossref
Crossref
Irene Cortese & Henry F. McFarland. 2008. Clinical Immunology. Clinical Immunology
963
975
.
Kimberly M. Winges, Donald H. Gilden, Jeffrey L. Bennett, Xiaoli Yu, Alanna M. Ritchie & Gregory P. Owens. (2007) Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. Journal of Neuroimmunology 192:1-2, pages 226-234.
Crossref
Crossref
Gregory P. Owens, Kimberly M. Winges, Alanna M. Ritchie, Sydni Edwards, Mark P. Burgoon, Laura Lehnhoff, Kirsten Nielsen, John Corboy, Donald H. Gilden & Jeffrey L. Bennett. (2007) VH4 Gene Segments Dominate the Intrathecal Humoral Immune Response in Multiple Sclerosis. The Journal of Immunology 179:9, pages 6343-6351.
Crossref
Crossref